Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.

[1]  H. Gollnick,et al.  Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment. , 2004, Cutis.

[2]  A. Rübig Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties. , 2003, Climacteric : the journal of the International Menopause Society.

[3]  G. Morgante,et al.  Different effectiveness of cyproterone acetate doses in treatment of acne , 2003, Clinical endocrinology.

[4]  A. Linneberg,et al.  Have Oral Contraceptives Reduced the Prevalence of Acne? A Population-Based Study of Acne vulgaris, Tobacco Smoking and Oral Contraceptives , 2002, Dermatology.

[5]  C. Gerlinger,et al.  The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea. , 2002, Cutis.

[6]  J. C. Shaw Acne: effect of hormones on pathogenesis and management. , 2002, American journal of clinical dermatology.

[7]  J. C. Shaw Low-dose adjunctive spironolactone in the treatment of acne in women: a retrospective analysis of 85 consecutively treated patients. , 2000, Journal of the American Academy of Dermatology.

[8]  R Krattenmacher,et al.  Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. , 2000, Contraception.

[9]  A. Kowald,et al.  Inhibition of skin 5α-reductase by oral contraceptive progestins in vitro , 2000 .

[10]  H. Gollnick,et al.  Efficacité de l'acétate de cyprotérone oral associé à l'éthinylestradiol dans le traitement de l'acné tardive de type facial , 1999 .

[11]  M. Lebwohl,et al.  Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. , 1997, Journal of the American Academy of Dermatology.

[12]  J. Jorizzo,et al.  Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial. , 1997 .

[13]  G. Singh,et al.  Spironolactone and cimetidine in treatment of acne. , 1988, Acta dermato-venereologica.

[14]  W. Cunliffe,et al.  Tolerance of spironolactone , 1987 .

[15]  P. Wise,et al.  Oral spironolactone: an effective treatment for acne vulgaris in women , 1986, The British journal of dermatology.

[16]  W. Cunliffe,et al.  Oral spironolactone therapy for female patients with acne, hirsutism or androgenic alopecia , 1985, The British journal of dermatology.

[17]  P. Wise,et al.  Oral spironolactone improves acne vulgaris and reduces sebum excretion , 1984, The British journal of dermatology.